Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Conmed Q2 2024 Adj. EPS $0.98 Beats $0.91 Estimate, Sales $332.097M Miss $332.325M Estimate

Author: Benzinga Newsdesk | July 31, 2024 05:04pm
Conmed (NYSE:CNMD) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.91 by 7.69 percent. The company reported quarterly sales of $332.097 million which missed the analyst consensus estimate of $332.325 million by 0.07 percent. This is a 4.55 percent increase over sales of $317.652 million the same period last year.

Posted In: CNMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist